Table A2.
Resistance rates of isolates in 102 patients with liver cirrhosis and bacteremia caused by ESBLEC and NESBLEC.
| Antimicrobials | ESBLEC (n = 51) | NESBLEC (n = 51) | p Value |
|---|---|---|---|
| Amikacin | 12 | 0 | <0.001 |
| Gentamicin | 35 | 8 | <0.001 |
| Ciprofloxacin | 42 | 10 | <0.001 |
| Imipenem | 0 | 0 | 1.0 |
| Ampicillin–sulbactam | 46 | 26 | <0.001 |
| Cefoxitin | 27 | 10 | 0.001 |
| TMP–SMZ a | 33 | 23 | 0.04 |
| Tigecycline | 1 | 0 | 1.0 |
| Minocycline | 15 | 21 | 0.2 |
| Ciprofloxacin and TMP–SMZ a | 26 | 6 | <0.001 |
| Ciprofloxacin and gentamicin | 29 | 4 | <0.001 |
| TMP–SMZ a and gentamicin | 23 | 5 | <0.001 |
a TMP–SMZ: trimethoprim–sulfamethoxazole.